Pancreatic Cancer Research

Clinical trialObservationalWithdrawn

Medication Adherence and Non-adherence in Adults With Rare Disease

A Longitudinal, Digital Study Using the Medication Adherence Reasons Scale (MAR-Scale) to Identify the Reasons for Non-adherence to Medications in Rare Disease

Outcome
Stopped earlyLiquidation of sponsor (Business decision)
Phase
Observational
Status
Withdrawn
Study type
Observational
Planned start
January 2021
Planned end
September 2022
Enrollment
0 participants
Sites
0
Primary outcomes
To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.; To use the MAR-Scale to determine the extent of non-adherence to specific medications indicated to treat a range of rare diseases.
Sponsor type
Academic / other
Results posted
No
Last update
12 May 2022

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The purpose of this study is to use the Medication Adherence Reasons Scale (MAR-Scale) to determine the extent of non-adherence to specific medications indicated to treat cystic fibrosis, hemophilia (A or B), idiopathic pulmonary fibrosis, myasthenia gravis, and sickle cell disease, and to identify the top patient-reported reasons for non-adherence. Internal reliability of the MAR-Scale will also be assessed in each condition.